Roche France
Roche France (Roche SAS) is the French subsidiary of F. Hoffmann-La Roche Ltd, developing and commercializing innovative pharmaceuticals and diagnostic solutions across oncology, ophthalmology, immunology, and rare diseases for healthcare professionals, patients, and institutions in France.
- Company typePrivate
- Founded1896
- HeadquartersBagnolet, France
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Roche France does
Roche France (legal entity Roche SAS, SIREN 552 012 031) is the French subsidiary of Swiss pharmaceutical group F. Hoffmann-La Roche Ltd, headquartered in Basel. Founded in 1896 and operating from Boulogne-Billancourt, Roche France employs 10,000+ people and runs two principal business divisions: Roche Pharma France, which develops and commercializes innovative medicines across oncology, ophthalmology, immunology, neuroscience, hematology, and rare diseases; and Roche Diagnostics France, which provides diagnostic products and services to healthcare professionals for patient diagnosis and monitoring. The company also operates Roche Diabetes Care and maintains dedicated digital platforms including RochePro (a healthcare professional portal) and Wikiboop (a patient-facing mobile health data application), plus the Timkl data analytics subsidiary.
The company generates revenue primarily through pharmaceutical product sales (prescription medicines to healthcare providers and institutions) and diagnostic hardware sales, distributed via field sales representatives targeting hospitals, pharmacy networks, and direct healthcare professional engagement. Pricing is managed through healthcare systems, insurance reimbursement, and institutional procurement rather than publicly disclosed pricing. Roche France goes to market through a multi-channel approach including dedicated medical information services available 24/7, national awareness campaigns across TV/radio/digital, the RochePro professional portal, and active social media presence.
The company serves healthcare professionals (physicians, pharmacists, nurses), patients and patient advocates, and the general public through a horizontal segmentation approach. It maintains regulatory compliance with GDPR/RGPD, RGAA accessibility standards, and pharmaceutical quality frameworks. President Jean-François Brochard leads the French entity, which has recently expanded strategic partnerships including the Care Forward startup accelerator with Doctolib and AP-HP at STATION F, and a long-standing alliance with Chugai for hemophilia therapeutics.
Roche France firmographics
Firmographics- Name
- Roche France
- Legal name
- Roche SAS
- Website
- https://roche.fr
- Company type
- Private
- Founded year
- 1896
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Roche France (Roche SAS) is the French subsidiary of F. Hoffmann-La Roche Ltd, developing and commercializing innovative pharmaceuticals and diagnostic solutions across oncology, ophthalmology, immunology, and rare diseases for healthcare professionals, patients, and institutions in France.
- Ownership category
- akta.pro rank
Roche France industry classification
Industry- Product category
- Pharmaceuticals and Diagnostics
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Oncology Specialty Pharmaceuticals (HLAIACAA)
- akta.pro secondary industries
- Ophthalmology Pharmaceuticals (HLAIAAAL), Neurology & CNS Specialty Pharmaceuticals (HLAIACAC)
Keywords
Where Roche France is headquartered
LocationHeadquarters
- HQ city
- Bagnolet
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Roche France business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- Pharmaceutical products: Roche develops and commercializes innovative medicines across multiple therapeutic areas including oncology, ophthalmology, immunology, neuroscience, and rare diseases. Revenue is generated through prescription drug sales to healthcare providers and institutions.
- Diagnostic solutions: Roche provides diagnostic products and services to healthcare professionals for patient diagnosis and monitoring, supporting treatment decisions.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Roche France product offering
Product offeringCore offering
Roche France develops, manufactures, and commercializes innovative prescription medicines across oncology, ophthalmology, immunology, neuroscience, hematology, and rare diseases under the Roche Pharma business. It also delivers in vitro diagnostic products and instruments through Roche Diagnostics, diabetes management products through Roche Diabetes Care, and operates the RochePro healthcare-professional portal and Wikiboop patient application for digital engagement.
Product overview
Roche France operates as a major pharmaceutical company with two main business units: Roche Pharma (innovative medicines) and Roche Diagnostics (diagnostic solutions), complemented by Roche Diabetes Care and RochePro professional platform. The portfolio includes treatments across oncology (breast cancer, liver cancer, lymphoma), ophthalmology (DMLA/wet AMD, diabetic macular edema), hemophilia, multiple sclerosis, and other therapeutic areas. RochePro serves as a dedicated portal for healthcare professionals, while Wikiboop is a patient-facing mobile application. The company emphasizes personalized medicine through biomarker analysis and advanced diagnostics.
Differentiator
Problem solved
Functional benefit
Brands
- RochePro: Healthcare professional portal for medical information and resources
- Wikiboop
- Roche Diabetes Care
- Roche Diagnostics
Products and services
- Roche Pharma France Roche Pharma France develops and commercializes innovative prescription medicines to address unmet medical needs across oncology (breast, liver, lymphoma), ophthalmology (wet AMD/DMLA, diabetic macular edema), hemophilia, multiple sclerosis, immunology, neuroscience, hematology, respiratory diseases, and rare diseases for French healthcare professionals and institutions.
- Roche Diagnostics Roche Diagnostics provides in vitro diagnostic products, instruments, and services to French healthcare professionals, delivering precise and rapid results that support patient management and treatment decisions.
- Roche Diabetes Care Roche Diabetes Care provides products and solutions for diabetes management as part of Roche's broader French healthcare portfolio, supporting patients and healthcare professionals in monitoring and treating diabetes.
- RochePro RochePro is a personalized online professional space for physicians, pharmacists, and nurses in France, giving them access to medical information, product resources, tutorials, and thematic fact sheets to support daily practice and patient consultations.
- Wikiboop Wikiboop is a patient-facing mobile application for tracking and exporting personal health data, with encrypted storage on the user's device and optional cloud export, marketed by Roche France under a dedicated privacy policy.
Companies that use Roche France
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
Roche France technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Roche France partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered major and core.
- DoctolibmajorDoctolib, l'Hôtel-Dieu (AP-HP) and Roche launched Care Forward, a unique support program dedicated to health technologies for European startups at STATION F. This unprecedented alliance aims to support healthcare innovation through a dedicated accelerator program.
- Hôtel-Dieu (AP-HP)majorPartnership with Hôtel-Dieu (AP-HP) as part of the Care Forward program with Doctolib and Roche to support European health tech startups at STATION F.
- ChugaicoreRoche-Chugai alliance for hemophilia, advancing treatment through scientific innovation and developing new therapeutic approaches. Chugai collaborates with Roche on co-promotion of certain medications and shares commercial and medical activities.
- STATION FmajorSTATION F hosts the Care Forward program, an accelerator for European health tech startups, in partnership with Doctolib, Hôtel-Dieu (AP-HP), and Roche.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
Roche France competitors and assessment
Company assessmentDirect peers
- Sanofi: France's largest domestic pharmaceutical company headquartered in Paris, operating across multiple therapeutic areas (immunology, oncology, rare diseases, vaccines) with comparable pharma-plus-consumer health footprint and similar French commercial scale.
- Novartis: Basel-headquartered Swiss pharma with major French operations, offering innovative branded medicines across oncology, ophthalmology, neuroscience, and cardiovascular — the most structurally comparable peer to Roche France in therapeutic breadth and European commercial model.
- Servier: France's second-largest pharmaceutical company by domestic presence, privately held, focused on oncology, cardiology, and rare diseases — directly comparable as a French-headquartered multi-therapeutic innovator competing for the same hospital accounts.
- Ipsen: French specialty pharmaceutical company headquartered in Paris, with focused presence in oncology, neuroscience, and rare diseases — a competing French mid-cap innovator targeting the same specialist prescriber base.
Broad incumbents
- Pfizer: US-based global pharmaceutical company with substantial French commercial presence (Paris office), broad multi-therapeutic portfolio, and direct competition in oncology, ophthalmology, and rare diseases markets.
- Bristol-Myers Squibb: US-headquartered major pharma with French commercial operations, deep oncology and hematology presence (immuno-oncology, hematology franchises), directly competing in the same specialty hospital channels.
- AstraZeneca: UK-headquartered global pharma with significant French operations, strong oncology and rare disease pipeline — competes head-to-head with Roche France for the same hospital accounts and clinical trial sites across France.
- AbbVie: US-headquartered pharma with French operations, strong immunology, oncology, and neuroscience (including migraine) franchises that overlap with Roche France's stated therapeutic focus areas.
- Merck & Co (MSD): US-based pharmaceutical leader with French operations, strong oncology (Keytruda) and ophthalmology portfolios — directly competitive in the same hospital-driven therapeutic categories that anchor Roche France's revenue.
- GSK: UK-headquartered global pharmaceutical company with established French operations, competing across vaccines, specialty medicines, and HIV — sharing the same French reimbursement pathways and hospital access dynamics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Roche France social profiles
Digital presenceRoche France compliance and trust
Trust signalCompliance3 records
Roche France financial estimates
Financial estimateRevenue estimate
Valuation estimate
Roche France leadership team
Management profileNumber of profiles
Profiles1 record
Roche France subsidiaries and ownership
Company hierarchySubsidiaries4 records
Roche France funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Roche France M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Roche France
What does Roche France do?
Roche France develops, manufactures, and commercializes innovative prescription medicines across oncology, ophthalmology, immunology, neuroscience, hematology, and rare diseases under the Roche Pharma business. It also delivers in vitro diagnostic products and instruments through Roche Diagnostics, diabetes management products through Roche Diabetes Care, and operates the RochePro healthcare-professional portal and Wikiboop patient application for digital engagement.
Is Roche France a public or private company?
Roche France is a private company. It is classified as corporate owned and is currently operating.
When was Roche France founded?
Roche France was founded in 1896. It employs 5,001 to 10,000 people.
Where is Roche France based?
Roche France is headquartered in Bagnolet, France, in the Europe region.
How does Roche France make money?
Two revenue lines are on record. Pharmaceutical products are the primary driver. The others are diagnostic solutions.
Who are Roche France's main competitors?
Direct peers on record are Sanofi, Novartis, Servier and Ipsen. Broad incumbents are Pfizer, Bristol-Myers Squibb, AstraZeneca, AbbVie, Merck & Co (MSD) and GSK.
Does Roche France have an API?
No public API is recorded for Roche France.
What industry is Roche France in?
Roche France's product category is Pharmaceuticals and Diagnostics. Its primary akta.pro industry code is HLAIACAA, Oncology Specialty Pharmaceuticals, with a secondary code of HLAIAAAL, Ophthalmology Pharmaceuticals. Its NAICS code is 32541 and its SIC code is 2834.